These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 4838250)

  • 41. EFFECTS OF FIBRINOLYTIC AGENTS AND HEPARIN ON BLOOD COAGULATION IN DOGS.
    LEWIS JH; SHIRAKAWA M
    Am J Physiol; 1964 Nov; 207():1049-52. PubMed ID: 14237448
    [No Abstract]   [Full Text] [Related]  

  • 42. [Stability of the anticoagulating effect of calcium and sodium heparin, injected subcutaneously].
    Langer B; Pinto WC; Maia RA; Kwang WT; Leão LE
    AMB Rev Assoc Med Bras; 1978 Apr; 24(4):121-3. PubMed ID: 308244
    [No Abstract]   [Full Text] [Related]  

  • 43. Antithrombin III during cardiac surgery: effect on response of activated clotting time to heparin and relationship to markers of hemostatic activation.
    Despotis GJ; Levine V; Joist JH; Joiner-Maier D; Spitznagel E
    Anesth Analg; 1997 Sep; 85(3):498-506. PubMed ID: 9296400
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Neutralization of low molecular weight heparin Kabi 2165 by protamine chloride].
    Harenberg J; Giese C; Knödler A; Zimmermann R; Schettler G
    Klin Wochenschr; 1986 Nov; 64(22):1171-5. PubMed ID: 3807263
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The activity state of factor VII in plasma: two pathways for the cold promoted activation of factor VII.
    Muller AD; van Deijk WA; Devilée PP; van Dam-Mieras MC; Hemker HC
    Br J Haematol; 1986 Feb; 62(2):367-77. PubMed ID: 3484966
    [TBL] [Abstract][Full Text] [Related]  

  • 46. THE EFFECT OF HEPARIN AND EPSILON-AMINOCAPROIC ACID ON THE COAGULATION IN HYPOTHERMIC DOGS.
    JOHANSSON BW; NILSSON IM
    Acta Physiol Scand; 1964 Mar; 60():267-77. PubMed ID: 14131840
    [No Abstract]   [Full Text] [Related]  

  • 47. Heparin blunts endotoxin-induced coagulation activation.
    Pernerstorfer T; Hollenstein U; Hansen J; Knechtelsdorfer M; Stohlawetz P; Graninger W; Eichler HG; Speiser W; Jilma B
    Circulation; 1999 Dec 21-28; 100(25):2485-90. PubMed ID: 10604885
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Principles of the treatment of hypercoagulabilities with a rational anticoagulant therapy].
    Raby C
    Presse Med (1893); 1969 Jan; 77(1):17-9. PubMed ID: 5785756
    [No Abstract]   [Full Text] [Related]  

  • 49. Effect of heparin and Bivalirudin on the kinetics of clot formation: Viscoelastic coagulation testing.
    Hasija S; Kapoor PM
    Ann Card Anaesth; 2017; 20(1):122. PubMed ID: 28074815
    [No Abstract]   [Full Text] [Related]  

  • 50. Preparation of heparin-linked agarose and its interaction with plasma.
    Danishefsky I; Tzeng F
    Thromb Res; 1974 Feb; 4(2):237-46. PubMed ID: 4831002
    [No Abstract]   [Full Text] [Related]  

  • 51. Kinetics of the anticoagulant effect of heparin.
    Estes JW
    JAMA; 1970 Jun; 212(9):1492-5. PubMed ID: 5467541
    [No Abstract]   [Full Text] [Related]  

  • 52. [Effect of exogenous heparin on heparinemia and coagulation in coronary arteriosclerosis].
    Szigeti I; Kótay-Lákatos E; Vertán MZ; Kiss R
    Med Interna (Bucur); 1967 May; 19(5):549-52. PubMed ID: 6077944
    [No Abstract]   [Full Text] [Related]  

  • 53. [Anticoagulant treatment in myocardial infarct].
    Bukowski Z
    Wiad Lek; 1971 Mar; 24(5):433-7. PubMed ID: 4251758
    [No Abstract]   [Full Text] [Related]  

  • 54. Effects of heparin, haemodilution and aprotinin on kaolin-based activated clotting time: in vitro comparison of two different point of care devices.
    Dalbert S; Ganter MT; Furrer L; Klaghofer R; Zollinger A; Hofer CK
    Acta Anaesthesiol Scand; 2006 Apr; 50(4):461-8. PubMed ID: 16548858
    [TBL] [Abstract][Full Text] [Related]  

  • 55. In vitro effects of a kaolin-coated hemostatic dressing on anticoagulated blood.
    Cripps MW; Cornelius CC; Nakonezny PA; Vazquez N; Wey JC; Gales PE
    J Trauma Acute Care Surg; 2018 Sep; 85(3):485-490. PubMed ID: 29851903
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [New data on the limitations of the Howell time in the control of heparinotherapy].
    Lalande G; Capel P; Fondu P
    Acta Clin Belg; 1981; 36(6):294-9. PubMed ID: 7331671
    [No Abstract]   [Full Text] [Related]  

  • 57. [Apparatus for automatic determination of blood tolerance to heparin].
    Lakin KM; Efimov VS; Barsukov II
    Farmakol Toksikol; 1970; 33(3):371-6. PubMed ID: 5453037
    [No Abstract]   [Full Text] [Related]  

  • 58. Heparin lowers plasma levels of activated factor VII.
    Pernerstorfer T; Jilma B; Eichler HG; Aull S; Handler S; Speiser W
    Br J Haematol; 1999 Jun; 105(4):1127-9. PubMed ID: 10554832
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Mechanism of prolonged hypocoagulation appearing after intratracheal administration of heparin].
    Efimov VS; Rumiantseva AG; Golovleva OA; Rozkin MIa
    Biull Eksp Biol Med; 1992 May; 113(5):509-12. PubMed ID: 1421273
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Letter: The heparin thrombin clotting-time.
    Green PJ
    Lancet; 1975 Apr; 1(7910):799. PubMed ID: 48020
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.